Cargando…

Costs and financial feasibility of malaria elimination

The marginal costs and benefits of converting malaria programmes from a control to an elimination goal are central to strategic decisions, but empirical evidence is scarce. We present a conceptual framework to assess the economics of elimination and analyse a central component of that framework—pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabot, Oliver, Cohen, Justin M, Hsiang, Michelle S, Kahn, James G, Basu, Suprotik, Tang, Linhua, Zheng, Bin, Gao, Qi, Zou, Linda, Tatarsky, Allison, Aboobakar, Shahina, Usas, Jennifer, Barrett, Scott, Cohen, Jessica L, Jamison, Dean T, Feachem, Richard GA
Formato: Texto
Lenguaje:English
Publicado: Lancet Publishing Group 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044845/
https://www.ncbi.nlm.nih.gov/pubmed/21035839
http://dx.doi.org/10.1016/S0140-6736(10)61355-4
_version_ 1782198785796997120
author Sabot, Oliver
Cohen, Justin M
Hsiang, Michelle S
Kahn, James G
Basu, Suprotik
Tang, Linhua
Zheng, Bin
Gao, Qi
Zou, Linda
Tatarsky, Allison
Aboobakar, Shahina
Usas, Jennifer
Barrett, Scott
Cohen, Jessica L
Jamison, Dean T
Feachem, Richard GA
author_facet Sabot, Oliver
Cohen, Justin M
Hsiang, Michelle S
Kahn, James G
Basu, Suprotik
Tang, Linhua
Zheng, Bin
Gao, Qi
Zou, Linda
Tatarsky, Allison
Aboobakar, Shahina
Usas, Jennifer
Barrett, Scott
Cohen, Jessica L
Jamison, Dean T
Feachem, Richard GA
author_sort Sabot, Oliver
collection PubMed
description The marginal costs and benefits of converting malaria programmes from a control to an elimination goal are central to strategic decisions, but empirical evidence is scarce. We present a conceptual framework to assess the economics of elimination and analyse a central component of that framework—potential short-term to medium-term financial savings. After a review that showed a dearth of existing evidence, the net present value of elimination in five sites was calculated and compared with effective control. The probability that elimination would be cost-saving over 50 years ranged from 0% to 42%, with only one site achieving cost-savings in the base case. These findings show that financial savings should not be a primary rationale for elimination, but that elimination might still be a worthy investment if total benefits are sufficient to outweigh marginal costs. Robust research into these elimination benefits is urgently needed.
format Text
id pubmed-3044845
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Lancet Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-30448452011-03-14 Costs and financial feasibility of malaria elimination Sabot, Oliver Cohen, Justin M Hsiang, Michelle S Kahn, James G Basu, Suprotik Tang, Linhua Zheng, Bin Gao, Qi Zou, Linda Tatarsky, Allison Aboobakar, Shahina Usas, Jennifer Barrett, Scott Cohen, Jessica L Jamison, Dean T Feachem, Richard GA Lancet Series The marginal costs and benefits of converting malaria programmes from a control to an elimination goal are central to strategic decisions, but empirical evidence is scarce. We present a conceptual framework to assess the economics of elimination and analyse a central component of that framework—potential short-term to medium-term financial savings. After a review that showed a dearth of existing evidence, the net present value of elimination in five sites was calculated and compared with effective control. The probability that elimination would be cost-saving over 50 years ranged from 0% to 42%, with only one site achieving cost-savings in the base case. These findings show that financial savings should not be a primary rationale for elimination, but that elimination might still be a worthy investment if total benefits are sufficient to outweigh marginal costs. Robust research into these elimination benefits is urgently needed. Lancet Publishing Group 2010-11-06 /pmc/articles/PMC3044845/ /pubmed/21035839 http://dx.doi.org/10.1016/S0140-6736(10)61355-4 Text en © 2010 Elsevier Ltd. All rights reserved. This document may be redistributed and reused, subject to certain conditions (http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0) .
spellingShingle Series
Sabot, Oliver
Cohen, Justin M
Hsiang, Michelle S
Kahn, James G
Basu, Suprotik
Tang, Linhua
Zheng, Bin
Gao, Qi
Zou, Linda
Tatarsky, Allison
Aboobakar, Shahina
Usas, Jennifer
Barrett, Scott
Cohen, Jessica L
Jamison, Dean T
Feachem, Richard GA
Costs and financial feasibility of malaria elimination
title Costs and financial feasibility of malaria elimination
title_full Costs and financial feasibility of malaria elimination
title_fullStr Costs and financial feasibility of malaria elimination
title_full_unstemmed Costs and financial feasibility of malaria elimination
title_short Costs and financial feasibility of malaria elimination
title_sort costs and financial feasibility of malaria elimination
topic Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044845/
https://www.ncbi.nlm.nih.gov/pubmed/21035839
http://dx.doi.org/10.1016/S0140-6736(10)61355-4
work_keys_str_mv AT sabotoliver costsandfinancialfeasibilityofmalariaelimination
AT cohenjustinm costsandfinancialfeasibilityofmalariaelimination
AT hsiangmichelles costsandfinancialfeasibilityofmalariaelimination
AT kahnjamesg costsandfinancialfeasibilityofmalariaelimination
AT basusuprotik costsandfinancialfeasibilityofmalariaelimination
AT tanglinhua costsandfinancialfeasibilityofmalariaelimination
AT zhengbin costsandfinancialfeasibilityofmalariaelimination
AT gaoqi costsandfinancialfeasibilityofmalariaelimination
AT zoulinda costsandfinancialfeasibilityofmalariaelimination
AT tatarskyallison costsandfinancialfeasibilityofmalariaelimination
AT aboobakarshahina costsandfinancialfeasibilityofmalariaelimination
AT usasjennifer costsandfinancialfeasibilityofmalariaelimination
AT barrettscott costsandfinancialfeasibilityofmalariaelimination
AT cohenjessical costsandfinancialfeasibilityofmalariaelimination
AT jamisondeant costsandfinancialfeasibilityofmalariaelimination
AT feachemrichardga costsandfinancialfeasibilityofmalariaelimination